These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 18041638

  • 1. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.
    Gupta PN, Khatri K, Goyal AK, Mishra N, Vyas SP.
    J Drug Target; 2007 Dec; 15(10):701-13. PubMed ID: 18041638
    [Abstract] [Full Text] [Related]

  • 2. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization.
    Gupta PN, Vyas SP.
    Colloids Surf B Biointerfaces; 2011 Jan 01; 82(1):118-25. PubMed ID: 20843665
    [Abstract] [Full Text] [Related]

  • 3. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS, Vyas SP.
    Vaccine; 2006 May 08; 24(19):4201-11. PubMed ID: 16446012
    [Abstract] [Full Text] [Related]

  • 4. Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B.
    Mishra N, Tiwari S, Vaidya B, Agrawal GP, Vyas SP.
    J Drug Target; 2011 Jan 08; 19(1):67-78. PubMed ID: 20334603
    [Abstract] [Full Text] [Related]

  • 5. Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation.
    Gupta PN, Mahor S, Rawat A, Khatri K, Goyal A, Vyas SP.
    Int J Pharm; 2006 Aug 02; 318(1-2):163-73. PubMed ID: 16621367
    [Abstract] [Full Text] [Related]

  • 6. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.
    He XW, Wang F, Jiang L, Li J, Liu SK, Xiao ZY, Jin XQ, Zhang YN, He Y, Li K, Guo YJ, Sun SH.
    J Gen Virol; 2005 Mar 02; 86(Pt 3):601-610. PubMed ID: 15722520
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B Antigen Loaded Biodegradable Polymeric Nanoparticles: Formulation Optimization and In-vivo Immunization in BALB/c Mice.
    Dewangan HK, Singh S, Maurya L, Srivastava A.
    Curr Drug Deliv; 2018 Mar 02; 15(8):1204-1215. PubMed ID: 29866006
    [Abstract] [Full Text] [Related]

  • 8. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS, Singh P, Prabakaran D, Mishra V, Vyas SP.
    J Pharm Pharmacol; 2004 Oct 02; 56(10):1243-50. PubMed ID: 15482638
    [Abstract] [Full Text] [Related]

  • 9. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
    Thomas C, Rawat A, Hope-Weeks L, Ahsan F.
    Mol Pharm; 2011 Apr 04; 8(2):405-15. PubMed ID: 21189035
    [Abstract] [Full Text] [Related]

  • 10. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
    Jain S, Singh P, Mishra V, Vyas SP.
    Immunol Lett; 2005 Oct 15; 101(1):41-9. PubMed ID: 15869802
    [Abstract] [Full Text] [Related]

  • 11. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V, Jain V, Sudheesh MS, Jaganathan KS, Murthy PK, Kohli DV.
    Int J Pharm; 2011 Apr 15; 408(1-2):50-7. PubMed ID: 21291968
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS, Cao M, Wong WW, Fischer KP, Addison WR, Kwon GS, Tyrrell DL, Samuel J.
    J Control Release; 2005 Jan 20; 102(1):85-99. PubMed ID: 15653136
    [Abstract] [Full Text] [Related]

  • 13. Development and characterization of LTA-appended chitosan nanoparticles for mucosal immunization against hepatitis B.
    Mishra N, Khatri K, Gupta M, Vyas SP.
    Artif Cells Nanomed Biotechnol; 2014 Aug 20; 42(4):245-55. PubMed ID: 23815286
    [Abstract] [Full Text] [Related]

  • 14. Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes).
    Shukla A, Khatri K, Gupta PN, Goyal AK, Mehta A, Vyas SP.
    J Pharm Pharm Sci; 2008 Aug 20; 11(1):59-66. PubMed ID: 18445364
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.
    Jain AK, Goyal AK, Gupta PN, Khatri K, Mishra N, Mehta A, Mangal S, Vyas SP.
    J Control Release; 2009 Jun 05; 136(2):161-9. PubMed ID: 19239919
    [Abstract] [Full Text] [Related]

  • 16. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
    Feng L, Zhou XJ, Wang SC, Jiang Y, Qi XR.
    Yao Xue Xue Bao; 2006 Feb 05; 41(2):132-7. PubMed ID: 16671543
    [Abstract] [Full Text] [Related]

  • 17. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D, Mangal S, Goswami R, Jaganathan KS.
    Eur J Pharm Biopharm; 2013 Nov 05; 85(3 Pt A):550-9. PubMed ID: 23831265
    [Abstract] [Full Text] [Related]

  • 18. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.
    Jiang T, Singh B, Li HS, Kim YK, Kang SK, Nah JW, Choi YJ, Cho CS.
    Biomaterials; 2014 Feb 05; 35(7):2365-73. PubMed ID: 24342722
    [Abstract] [Full Text] [Related]

  • 19. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
    Rajkannan R, Dhanaraju MD, Gopinath D, Selvaraj D, Jayakumar R.
    Vaccine; 2006 Jun 12; 24(24):5149-57. PubMed ID: 16713035
    [Abstract] [Full Text] [Related]

  • 20. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A, Katare OP, Singh B, Vyas SP.
    Int J Pharm; 2010 Jan 29; 385(1-2):47-52. PubMed ID: 19835938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.